跳至主要内容
临床试验/CTRI/2018/03/012385
CTRI/2018/03/012385已完成未知

A pilot Clinical study to assess the effect of Curcumin supplementation (CurQfen-The enhanced bioavailable formulation of curcumin)on liver health in chronic drinkers

Akay Flavours And Aromatics Pvt Ltd0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Chronic alcohol intake of more than six units per week. 1 unit is equal to 150 ml of wine or 360 ml of beer or 45 ml of 40 percentage alcohol
  • 2.Mild to moderate cases of alcoholic hepatitis
  • 3.Ratio of AST to ALT greater than 2
  • 4.Informed consent

排除标准

  • 1.Present with kidney failure (serum creatinine > 2.0 mg/dl) or in the process of renal dialysis
  • 2.Present with Viral hepatitis (ALT level >/equal to 3 times the upper limit)
  • 3.Receive any herbal medications or curcumin
  • 4.Subjects abstaining from alcohol for
  • more than 1 month
  • 5. concomitant symptomatic or asymptomatic bacterial
  • infection and severe bacterial infection
  • within the previous 3 months.
  • 6.Pregnancy or breastfeeding
  • 7.Have a history of gall bladder diseases or removal

研究者

发起方
Akay Flavours And Aromatics Pvt Ltd

相似试验

Effect of a a novel curcumin-galactomannoside... | 临床试验